By Eric Kroh ( June 21, 2016, 7:11 PM EDT) -- Sen. Michael S. Lee, R-Utah, on Tuesday railed against a 2010 PowerPoint presentation he said was prepared by a Wiley Rein LLP lawyer and described how pharmaceutical companies can use the U.S. Food and Drug Administration's Risk Evaluation and Mitigation Strategies for what he called "blatantly anti-competitive behavior."...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.